key: cord-1055154-vsr5o6n8
authors: Sluggett, Janet K; Dinh, Yen H; Wesselingh, Steven L; Inacio, Maria C; Caughey, Gillian E
title: National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 Pandemic in Australia
date: 2021-03-17
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab241
sha: 676948818677b731778d1b944f51040bb7ee9cae
doc_id: 1055154
cord_uid: vsr5o6n8

nan

M a n u s c r i p t pandemic in the United States (US) [1] . In Australia, where the cumulative case rate is 113.6/100,000 people compared to 8512/100,000 in the US (as of 02/28/21) [2] , the pandemic response included strict social distancing rules, border closures, employment and economic stimulus measures, and national lockdowns (March-May 2020), followed by additional state-based lockdowns (June-October 2020) [3] . We investigated outpatient antibiotic dispensing during the COVID-19 pandemic in Australia, where the overall rate of outpatient antibiotic utilization is high compared to other OECD countries [4, 5] .

Repatriation PBS (RPBS) Section 85 Date of Supply dataset [6] , we extracted the total monthly number of commonly utilized systemic antibiotics [4, 5] dispensed between October 2018 and September 2020. This dataset includes aggregated dispensing volume for all PBS/RPBS prescriptions dispensed through community pharmacies and some supplied by hospital pharmacies, updated monthly [6] . Quarterly national population projections [7] were used to determine the relative percentage change in dispensings per 100,000 individuals each month by comparing the monthly rate during October 2019-September 2020 with the corresponding month in the previous year (i.e., October 2019 rates were compared to October 2018). Ethical approval was not required as aggregated, publicly available data were analyzed.

In October 2019, antibiotic dispensing rates were similar or slightly lower than in October 2018 The initial peak and subsequent decline in antibiotic utilization in the early stages of the pandemic in Australia may reflect prescribing in advance or stockpiling. Utilization of empirical therapies for acute cystitis (trimethoprim and nitrofurantoin) quickly recovered while decreases in antibiotics commonly prescribed for respiratory infections (e.g., penicillins, macrolides) persisted. Australia experienced higher uptake of influenza vaccinations and low influenza case numbers in 2020 [8] , while the rate of general practitioner visits remained relatively stable as new telehealth/telephone services were introduced [9] . Together, this suggests observed changes in antibiotic utilization likely reflects decreased transmission of respiratory infections rather than decreased healthcare visits, although the impact of telehealth services on antibiotic prescribing requires further evaluation.

Our findings are nationally representative as all outpatient dispensings for government-subsidized systemic antibiotics are included. However, individual-level information such as age, geographical location, and non-government subsidized prescriptions are not captured in the dataset.

Although COVID-19 directly impacted only a fraction of individuals in Australia compared to the US [2] , substantial changes in outpatient antibiotic dispensing were observed in both countries in March-May 2020. Decreases in dispensings of beta lactams, macrolides and tetracyclines were sustained throughout June-September 2020 in Australia. We concur with King et al. [1] that timely surveillance is needed to determine if changes are sustained and to guide refinement of antimicrobial stewardship messages to stakeholders.

Trends in US Outpatient Antibiotic Prescriptions During the Coronavirus Disease 2019 Pandemic

Weekly Epidemiological Update -2

Accessed 9

for the Department of Parliamentary Services. COVID-19: a chronology of state and territory government announcements (up until

AURA 2019: third Australian report on antimicrobial use and resistance in human health

National trends in antibiotic use in Australian residential aged care facilities

Australian Government Department of Health. PBS and RPBS Section 85 Data of Supply Data

State/Territory, Sex and Age

Australian Influenza Surveillance Report -2020 National Influenza Season Summary. Canberra: Commonwealth of Australia

Impacts of COVID-19 on Medicare Benefits Scheme and Pharmaceutical Benefits Scheme service use

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t